Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Black Iron Inc
TSX:BKI
|
CA |
|
W
|
Winfarm SA
PAR:ALWF
|
FR |
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
EUDA Health Holdings Ltd
NASDAQ:EUDA
|
SG |
|
Impack Pratama Industri Tbk PT
IDX:IMPC
|
ID |
Wall Street
Price Targets
IKT Price Targets Summary
Inhibikase Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IKT
is 5.87 USD
with a low forecast of 3.03 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IKT's stock price target?
Price Target
5.87
USD
According to Wall Street analysts, the average 1-year price target for
IKT
is 5.87 USD
with a low forecast of 3.03 USD and a high forecast of 8.4 USD.